Venoocclusive disease of the liver after chemotherapy with vincristine, actinomycin D, and cyclophosphamide for the treatment of rhabdomyosarcoma. A report of the Intergroup Rhabdomyosarcoma Study Group. Childrens Cancer Group, the Pediatric Oncolog
about
Mylotarg (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantationPatterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma CommitteeCongenital infantile fibrosarcoma: Association with bleeding diathesis.Progress in the diagnosis and treatment of rhabdomyosarcoma and related soft tissue sarcomas.Veno-occlusive disease in a child with rhabdomyosarcoma after conventional chemotherapy: report of a case and review of the literature.Severe Hepatic Sinusoidal Obstruction Syndrome in a Child Receiving Vincristine, Actinomycin-D, and Cyclophosphamide for Rhabdomyosarcoma: Successful Treatment with DefibrotideVincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803.Hepatic sinusoidal obstruction syndrome during chemotherapy for childhood medulloblastoma: report of a case and review of the literature.45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.High Incidence of Veno-Occlusive Disease With Myeloablative Chemotherapy Following Craniospinal Irradiation in Children With Newly Diagnosed High-Risk CNS Embryonal Tumors: A Report From the Children's Oncology Group (CCG-99702).Fatal hepatic veno-occlusive disease with fibrinolysis as the cause of death during preoperative chemotherapy for nephroblastoma.Clinical severe hepatic venoocclusive disease during induction treatment of acute monoblastic leukemia managed with defibrotide.
P2860
Q28207989-27C9F15A-5F9E-41D6-8A76-0CE433793D20Q33396263-1A57A97C-545D-4D62-9A65-98C6561D5AE7Q33411676-E4D28420-29DE-4884-AE73-91E25FA92348Q33885722-D4CE35FC-7AB8-4316-B744-AECBAC9F193FQ37037513-8D7EEAF7-ACA2-4769-B65A-A8806553FA94Q37367452-C5F2E7C8-546A-4494-B9BF-5EDCCD923D02Q37412294-392B662F-A59B-40E7-97CA-212E2396BD2DQ37414178-16160E5E-C448-4A4B-861F-2F99D6FA4747Q38761564-FF3BCB41-8E3E-4D88-9FEF-E89D01F4CF9BQ40744398-CD115102-46FE-4633-9625-9E39E6A9317CQ42540021-D487C548-A40A-43FB-9880-A2B51DEF8196Q43938438-2A582596-6E57-49FA-9E52-396E6CE76ECE
P2860
Venoocclusive disease of the liver after chemotherapy with vincristine, actinomycin D, and cyclophosphamide for the treatment of rhabdomyosarcoma. A report of the Intergroup Rhabdomyosarcoma Study Group. Childrens Cancer Group, the Pediatric Oncolog
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Venoocclusive disease of the l ...... r Group, the Pediatric Oncolog
@en
Venoocclusive disease of the l ...... r Group, the Pediatric Oncolog
@nl
type
label
Venoocclusive disease of the l ...... r Group, the Pediatric Oncolog
@en
Venoocclusive disease of the l ...... r Group, the Pediatric Oncolog
@nl
prefLabel
Venoocclusive disease of the l ...... r Group, the Pediatric Oncolog
@en
Venoocclusive disease of the l ...... r Group, the Pediatric Oncolog
@nl
P2093
P2860
P1433
P1476
Venoocclusive disease of the l ...... r Group, the Pediatric Oncolog
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0142(19970615)79:12<2435::AID-CNCR21>3.0.CO;2-R
P407
P577
1997-06-01T00:00:00Z